Researchers at UBC are going to study the healing potential of marijuana thanks to a million-dollar donation from a medical cannabis company.
The money from National Green Biomed will be used to examine the drug’s therapeutic impact over five years.
The Richmond-based company, in existence less than a year, is awaiting approval from Health Canada to produce and sell medical marijuana.
It was founded by a group including private investment banker David Sidoo, who’s also a member of the UBC Board of Governors.
University researchers are already studying how cannabis can treat HIV, as well as alleviating pain and nausea linked to AIDS medications.
A study published earlier this year found HIV patients benefit from using marijuana daily.